Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...
Dr. Ash Kapoor, founder of Levitas One, speaks about how cutting-edge longevity science meets ancient wisdom to help us live ...
New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.
Scientists have turned to artifacts associated with Leonardo da Vinci on a quest to track down the legendary polymath’s elusive DNA.
Introduction Self-sampling for cervical cancer screening is a promising strategy to improve coverage and reduce strain on ...
Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback